T1	Participants 64 101	patients with diabetic polyneuropathy
T2	Participants 784 797	United States
T3	Participants 819 949	1019 men and women aged 18 to 74 years with either type 1 or type 2 diabetes and a sensory polyneuropathy attributable to diabetes
